Interventional Systems Announces FDA Expanded Use for Micromate™

Kitzbühel, Austria-based Interventional Systems has received US FDA 510(k) clearance for Micromate™, the robotic system for percutaneous procedures using CT optical navigation such as biopsies and ablations, to diagnose and treat conditions in the chest, abdomen, and musculoskeletal structures.

Micromate™ has been available in the US since 2021 for any percutaneous needle intervention performed under live imaging using Cone-Beam Computed Tomography (CBCT), Fluoro CT, or a Fluoroscope. This latest FDA clearance further expands its scope, including for integration with third-party navigation stations.

Micromate™ was first used successfully a year ago at St. Antonius Hospital in the Netherlands. Since then, it has been used regularly at several clinical sites across Europe for all indications and procedures requiring needles or instruments from 8-21G.

To view the source version, please click HERE.